.png){kind=icon}
Bioluminescence imaging: In vivo monitoring of tumor development, disease dissemination and treatment efficacy
Thank you for downloading this content.
Learn more about our oncology development capabilities or browse other oncology content.
Covance Is Now Labcorp Drug Development
We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.
-
-
Pan02-Luc: An orthotopic model of pancreatic cancer
-
CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies
-
EMT6-Luc: In vivo monitoring of metastatic development and treatment efficacy
-
4T1-luc2: An orthotopic mammary cancer odel to support novel immuno-oncology drug discovery
-
5TGM1-luc – A syngeneic murine model for multiple myeloma
-
786-O (pMMP-LucNeo) – A model for renal cell carcinoma
-
A20: Modeling B cell lymphoma in mice
-
Absolute counts by flow cytometry — maximize the accuracy of your immunophenotypic data interpretation
-
A deeper dive into the tumor-infiltrating T Cell immunophenotype
Labcorp is a leading global life sciences company that includes contract research and developmental services to the pharmaceutical, medical technology, crop protection and chemical industries.